The results revealed that in the cerebral cortex, there were no significant changes observed when comparing APP/PS1 transgenic AD model mice to their wild type control in terms of Cho/Cr, NAA/Cr, Glx/Cr, or mI/Cr ratios. This evidence concerns the gene PSEN1 and Alzheimer disease.